FOURTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTESNote and Warrant Purchase Agreement • October 10th, 2012 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
This Fourth Amendment (as amended, restated, supplemented or otherwise modified from time to time, the “Fourth Amendment”) dated as of October 4, 2012, among Marina Biotech, Inc., a Delaware corporation (the “Company”), MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Research”), and Cequent Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Cequent” and, together with the Company and Research, the “Companies”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”), amends (i) that certain Note and Warrant Purchase Agreement (as amended from time to time, the “Purchase Agreement”), dated as of February 10, 2012, among the Companies and the Purchasers and (ii) the Secured Promissory Notes (the “Notes”) issued to the Purchasers pursuant thereto. Capitalized terms used but not otherwise defined herein shall
LEASE TERMINATION AGREEMENTLease Termination Agreement • October 10th, 2012 • Marina Biotech, Inc. • Pharmaceutical preparations • Washington
THIS LEASE TERMINATION AGREEMENT (this “Agreement”) is entered into effective as of October 1, 2012 (“Effective Date”) by and between DITTY PROPERTIES LIMITED PARTNERSHIP, a Washington limited partnership (“Landlord”); and MARINA BIOTECH, INC., a Delaware corporation, f/k/a MDRNA, Inc., f/k/a Nastech Pharmaceutical Company, Inc. (“Tenant”).
